deCODE biostructures Expands Collaboration with InterMune
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
deCODE biostructures, Inc. announces the initiation of a third research project with InterMune, Inc. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target.
The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life™ technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.
